Literature DB >> 9403007

Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis.

N Johnson1, T T Ng, J M Parkin.   

Abstract

We have investigated the effect of the anticancer compound, camptothecin on Jurkat T-cells, a lymphoblastoid leukemic cell-line. Exposure to low concentrations led to rapid cessation of DNA (more than 95%) and RNA (more than 75%) synthesis. Perturbations to the cell cycle were observed following exposure which caused a significant accumulation of cells within G1 (P = 0.03) with a concomitant decrease in G2/M (P = 0.025). Concentrations below 0.1 microM could inhibit DNA synthesis but not induce apoptosis. Induction of apoptosis was dose dependent and could be detected as early as 3 h post exposure. The apoptotic population appeared to be derived from G1 and S-phase cells but not G2/M, coinciding with the cell cycle compartments in which DNA and RNA polymerases function. However, direct inhibition of DNA polymerase alone was not shown to be associated the induction of apoptosis or with a decrease in susceptibility to camptothecin-induced cell death. The effects of camptothecin on Jurkat T-cells and the potential mechanisms involved are discussed in the context of observations made in other transformed cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403007     DOI: 10.1016/s0145-2126(97)00077-5

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway.

Authors:  Robert J George; Mark A Sturmoski; Shrikant Anant; Courtney W Houchen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-01-03       Impact factor: 3.072

2.  New Arabidopsis thaliana cytochrome c partners: a look into the elusive role of cytochrome c in programmed cell death in plants.

Authors:  Jonathan Martínez-Fábregas; Irene Díaz-Moreno; Katiuska González-Arzola; Simon Janocha; José A Navarro; Manuel Hervás; Rita Bernhardt; Antonio Díaz-Quintana; Miguel Á De la Rosa
Journal:  Mol Cell Proteomics       Date:  2013-09-09       Impact factor: 5.911

3.  CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin.

Authors:  Yun Li; John E Shively
Journal:  Exp Cell Res       Date:  2013-03-07       Impact factor: 3.905

4.  Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination.

Authors:  Luciana Ferrara; Eric B Kmiec
Journal:  Nucleic Acids Res       Date:  2004-10-05       Impact factor: 16.971

5.  Structural and functional analysis of novel human cytochrome C targets in apoptosis.

Authors:  Jonathan Martínez-Fábregas; Irene Díaz-Moreno; Katiuska González-Arzola; Simon Janocha; José A Navarro; Manuel Hervás; Rita Bernhardt; Adrián Velázquez-Campoy; Antonio Díaz-Quintana; Miguel A De la Rosa
Journal:  Mol Cell Proteomics       Date:  2014-03-18       Impact factor: 5.911

6.  Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.

Authors:  Ying Wu; Ke-yong Wang; Zhi Li; Yun-peng Liu; Hiroto Izumi; Hidetaka Uramoto; Yoshifumi Nakayama; Ken-ichi Ito; Kimitoshi Kohno
Journal:  J Exp Clin Cancer Res       Date:  2014-12-24

7.  Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes.

Authors:  Mira Woitok; Elena Grieger; Olusiji A Akinrinmade; Susanne Bethke; Anh Tuan Pham; Christoph Stein; Rolf Fendel; Rainer Fischer; Stefan Barth; Judith Niesen
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

8.  Apoptosis assays with lymphoma cell lines: problems and pitfalls.

Authors:  M J Mattes
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

9.  Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells.

Authors:  Naohiro Seo; Yoshitaka Shirakura; Yoshiro Tahara; Fumiyasu Momose; Naozumi Harada; Hiroaki Ikeda; Kazunari Akiyoshi; Hiroshi Shiku
Journal:  Nat Commun       Date:  2018-01-30       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.